(S)-2-Phenyl-1-(thiazol-2-yl)ethanamine hydrochloride, 95.0%, 50mg

7-Bromo-2,3-dihydro-1H-inden-1-ol, 97%, 250mg

3-Fluorophenyl isothiocyanate, 99.0%, 25g

Pipeta microlitro monocanal mLINE® variable, 500 a 5000 µl, 1 unidad

6-Methoxy-2-(4-methyl-1,4-diazepan-1-yl)-4-((1-methylpiperidin-4-yl)amino)quinazolin-7-ol (trihydrochloride), 98%, 250mg

1-(4-chlorophenyl)-1H-pyrazole-3-carboxylic acid, 95.0%, 100mg

2-Methyl-4-(3-pyridyl)thiazole, 5g

4-Benzylthiomorpholine 1,1-Dioxide>98.0%(GC)5g

methyl (piperidin-4-ylsulfonyl)acetate hydrochloride, 95.0%, 500mg

4-Methoxyphenylacetone, 98.0%, 25g

N-Acetyl-epsilon-caprolactam>98.0%(GC)500g

1H-Indeno[5,4-f]quinoline-7-carboxylic acid, hexadecahydro-1,4a,6a-triMethyl-2-oxo-, Methyl ester, (4aR,4bS,6aS,7S,9aS,9bS,11aR)-, 98%, 250mg

1-(2-Chlorophenyl)-2,5-dimethyl-1H-pyrrole-3-carbaldehyde, 95.0%, 1g